{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:00:50Z","timestamp":1786132850438,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","funder":[{"DOI":"10.13039\/100009268","name":"Alport Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202860\/Z\/16\/Z"],"award-info":[{"award-number":["202860\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2021,8]]},"abstract":"\n Significance Statement<\/jats:title>\n \n Kidney disease severity is partly determined by modifier genes. These genes can be important therapeutic targets but are difficult to identify in patient populations. Our study demonstrates a novel mouse genetic approach using Diversity Outbred mice to identify modifier genes for X-linked Alport Syndrome. We identify several candidate modifier genes and validate the candidacy of\n Fmn1<\/jats:italic>\n . We show that a decrease in\n Fmn1<\/jats:italic>\n expression in\n Col4a5<\/jats:italic>\n knockout mice leads to a decrease in albuminuria and fewer podocyte protrusions in the glomerular basement membrane. Our approach can be easily adapted to identify modifier genes for other forms of kidney disease.\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n \n Mutations in\n COL4A5<\/jats:italic>\n are responsible for 80% of cases of X-linked Alport Syndrome (XLAS). Although genes that cause AS are well characterized, people with AS who have similar genetic mutations present with a wide variation in the extent of kidney impairment and age of onset, suggesting the activities of modifier genes.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We created a cohort of genetically diverse XLAS male and female mice using the Diversity Outbred mouse resource and measured albuminuria, GFR, and gene expression. Using a quantitative trait locus approach, we mapped modifier genes that can best explain the underlying phenotypic variation measured in our diverse population.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Genetic analysis identified several loci associated with the variation in albuminuria and GFR, including a locus on the X chromosome associated with X inactivation and a locus on chromosome 2 containing\n Fmn1<\/jats:italic>\n . Subsequent analysis of genetically reduced\n Fmn1<\/jats:italic>\n expression in\n Col4a5<\/jats:italic>\n knockout mice showed a decrease in albuminuria, podocyte effacement, and podocyte protrusions in the glomerular basement membrane, which support the candidacy of\n Fmn1<\/jats:italic>\n as a modifier gene for AS.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n With this novel approach, we emulated the variability in the severity of kidney phenotypes found in human patients with Alport Syndrome through albuminuria and GFR measurements. This approach can identify modifier genes in kidney disease that can be used as novel therapeutic targets.<\/jats:p>\n <\/jats:sec>","DOI":"10.1681\/asn.2020060777","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T15:10:15Z","timestamp":1622128215000},"page":"1961-1973","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Uncovering Modifier Genes of X-Linked Alport Syndrome Using a Novel Multiparent Mouse Model"],"prefix":"10.1681","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3538-4409","authenticated-orcid":false,"given":"Yuka","family":"Takemon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Wright","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, Bar Harbor, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Davenport","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Gatti","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, Bar Harbor, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Sheehan","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, Bar Harbor, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Letson","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, Bar Harbor, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly S.","family":"Savage","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, Bar Harbor, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lennon","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2808-1610","authenticated-orcid":false,"given":"Ron","family":"Korstanje","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, Bar Harbor, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8]]},"reference":[{"key":"B1-20240826","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ejhg.2011.237","article-title":"Clinical utility gene card for: Alport syndrome","volume":"20","author":"Hertz","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"B2-20240826","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport syndrome--insights from basic and clinical research","volume":"9","author":"Kruegel","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B3-20240826","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B4-20240826","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/0886022X.2016.1262266","article-title":"Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease","volume":"39","author":"Kelly","year":"2017","journal-title":"Ren Fail"},{"key":"B5-20240826","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.matbio.2016.08.005","article-title":"Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome","volume":"57-58","author":"Cosgrove","year":"2017","journal-title":"Matrix Biol"},{"key":"B6-20240826","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-011-1836-7","article-title":"Women and Alport syndrome","volume":"27","author":"Rheault","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B7-20240826","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00467-012-2138-4","article-title":"Alport Syndrome Research Collaborative: Clinical practice recommendations for the treatment of Alport syndrome: A statement of the Alport Syndrome Research Collaborative","volume":"28","author":"Kashtan","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B8-20240826","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: Natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B9-20240826","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9440(10)64892-4","article-title":"Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome","volume":"160","author":"Andrews","year":"2002","journal-title":"Am J Pathol"},{"key":"B10-20240826","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ki.2013.493","article-title":"A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen \u03b13\u03b14\u03b15(IV) trimers","volume":"85","author":"Korstanje","year":"2014","journal-title":"Kidney Int"},{"key":"B11-20240826","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35056009","article-title":"Modifier genes in mice and humans","volume":"2","author":"Nadeau","year":"2001","journal-title":"Nat Rev Genet"},{"key":"B12-20240826","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-linked Alport syndrome","volume":"15","author":"Rheault","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B13-20240826","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1534\/g3.114.013748","article-title":"Quantitative trait locus mapping methods for diversity outbred mice","volume":"4","author":"Gatti","year":"2014","journal-title":"G3 (Bethesda)"},{"key":"B14-20240826","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1152\/physiolgenomics.00118.2017","article-title":"FAR2 is associated with kidney disease in mice and humans","volume":"50","author":"Backer","year":"2018","journal-title":"Physiol Genomics"},{"key":"B15-20240826","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1534\/g3.115.022087","article-title":"The Mouse universal genotyping array: From substrains to subspecies","volume":"6","author":"Morgan","year":"2015","journal-title":"G3 (Bethesda)"},{"key":"B16-20240826","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/bioinformatics\/bty078","article-title":"Hierarchical analysis of RNA-seq reads improves the accuracy of allele-specific expression","volume":"34","author":"Raghupathy","year":"2018","journal-title":"Bioinformatics"},{"key":"B17-20240826","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/hmg\/ddp185","article-title":"Formin1 disruption confers oligodactylism and alters Bmp signaling","volume":"18","author":"Zhou","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B18-20240826","doi-asserted-by":"crossref","first-page":"35068","DOI":"10.1038\/srep35068","article-title":"Three-dimensional electron microscopy reveals the evolution of glomerular barrier injury","volume":"6","author":"Randles","year":"2016","journal-title":"Sci Rep"},{"key":"B19-20240826","doi-asserted-by":"crossref","first-page":"e1003853","DOI":"10.1371\/journal.pgen.1003853","article-title":"Genetic architecture of skewed X inactivation in the laboratory mouse","volume":"9","author":"Calaway","year":"2013","journal-title":"PLoS Genet"},{"key":"B20-20240826","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"B21-20240826","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1038\/ncomms7496","article-title":"Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy","volume":"6","author":"Madhusudhan","year":"2015","journal-title":"Nat Commun"},{"key":"B22-20240826","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-020-01884-x","article-title":"Genome-wide association study identifies new loci for albuminuria in the Japanese population","volume":"24","author":"Okuda","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"B23-20240826","doi-asserted-by":"crossref","first-page":"e2497","DOI":"10.1371\/journal.pone.0002497","article-title":"Formin 1-isoform IV deficient cells exhibit defects in cell spreading and focal adhesion formation","volume":"3","author":"Dettenhofer","year":"2008","journal-title":"PLoS One"},{"key":"B24-20240826","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1681\/ASN.2014040419","article-title":"Genetic background is a key determinant of glomerular extracellular matrix composition and organization","volume":"26","author":"Randles","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B25-20240826","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/ndt\/gfp551","article-title":"X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome","volume":"25","author":"Rheault","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B26-20240826","doi-asserted-by":"crossref","first-page":"E668","DOI":"10.1073\/pnas.1715124115","article-title":"A mixed modality approach towards Xi reactivation for Rett syndrome and other X-linked disorders","volume":"115","author":"Carrette","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27-20240826","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1681\/ASN.2004100871","article-title":"Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease","volume":"16","author":"Ninichuk","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2020060777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:25:00Z","timestamp":1786130700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2020060777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2020060777","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"2020-06-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}